XTX Topco’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-84,405
| Closed | -$186K | – | 2704 |
|
|
2025
Q1 | $186K | Sell |
84,405
-213,080
| -72% | -$469K | 0.01% | 1720 |
|
|
2024
Q4 | $455K | Sell |
297,485
-83
| -0% | -$127 | 0.04% | 839 |
|
|
2024
Q3 | $592K | Buy |
297,568
+243,363
| +449% | +$484K | 0.04% | 702 |
|
|
2024
Q2 | $190K | Sell |
54,205
-154,582
| -74% | -$541K | 0.02% | 1262 |
|
|
2024
Q1 | $578K | Buy |
208,787
+104,513
| +100% | +$290K | 0.08% | 403 |
|
|
2023
Q4 | $177K | Buy |
+104,274
| New | +$177K | 0.04% | 1002 |
|
|
2023
Q3 | – | Sell |
-407,825
| Closed | -$473K | – | 1756 |
|
|
2023
Q2 | $473K | Buy |
407,825
+171,851
| +73% | +$199K | 0.08% | 403 |
|
|
2023
Q1 | $356K | Sell |
235,974
-111,063
| -32% | -$168K | 0.07% | 515 |
|
|
2022
Q4 | $868K | Buy |
347,037
+265,914
| +328% | +$665K | 0.18% | 116 |
|
|
2022
Q3 | $342K | Buy |
81,123
+3,039
| +4% | +$12.8K | 0.08% | 423 |
|
|
2022
Q2 | $218K | Buy |
78,084
+57,648
| +282% | +$161K | 0.09% | 433 |
|
|
2022
Q1 | $117K | Buy |
+20,436
| New | +$117K | 0.05% | 491 |
|
|
2021
Q4 | – | Sell |
-26,811
| Closed | -$287K | – | 827 |
|
|
2021
Q3 | $287K | Buy |
+26,811
| New | +$287K | 0.1% | 352 |
|
|
2021
Q2 | – | Sell |
-11,872
| Closed | -$192K | – | 931 |
|
|
2021
Q1 | $192K | Buy |
+11,872
| New | +$192K | 0.09% | 509 |
|